Last reviewed · How we verify
A Prospective, Randomized, Placebo-Controlled, Crossover Study of the Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of "Off" Episodes in Patients With "On/Off" or "Wearing Off" Effects Associated With Late Stage Parkinson's Disease
The objective of this study was to measure the continued efficacy of apomorphine after previous exposure of at least three months duration.
Details
| Lead sponsor | Mylan Bertek Pharmaceuticals |
|---|---|
| Phase | Phase 2/Phase 3 |
| Status | COMPLETED |
| Enrolment | 16 |
| Start date | 1999-09 |
| Completion | 1999-11 |
Conditions
- Parkinson Disease
Interventions
- apomorphine HCl injection
Primary outcomes
- UPDRS Motor Score 20 minutes after dosing
Countries
United Kingdom